Bernstein, Richard A.

Cryptogenic stroke and underlying atrial fibrillation

Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 2,161

Predictors for atrial fibrillation detection after cryptogenic stroke: Results from CRYSTAL AF

Thijs, V. N., Brachmann, J., Morillo, C. A., Passman, R. S., Sanna, T., Bernstein, R. A., Diener, H.-C., Di Lazzaro, V., Rymer, M. M., Hogge, L., et al. (2016) · Neurology

Atrial Fibrillation Management and OutcomesCardiovascular and Diving-Related Complications

Cited by 170

Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study

PASSMAN, R., LEONG‐SIT, P., ANDREI, A., HUSKIN, A., TOMSON, T. T., BERNSTEIN, R., ELLIS, E., WAKS, J. W., & ZIMETBAUM, P. (2016) · Journal of Cardiovascular Electrophysiology

Atrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studies

Cited by 115

Letter by Bernstein et al Regarding Article, “Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects

Bernstein, R. A., Alberts, M. J., & Garcia, D. A. (2012) · Circulation

Atrial Fibrillation Management and OutcomesBlood transfusion and management

Cited by 4